Envelope Immunogen and Recombinant Antibody Production Core
$157,399U19FY2014AINIH
Fred Hutchinson Cancer Research Center, Seattle WA
Investigators
Linked publications & trials
Paper 31801073Paper 31345931Paper 30403372Paper 29933399Paper 28757252Paper 28003309Paper 27806295Paper 27610571Paper 27610569Paper 26907590Paper 26091035Paper 25504724
Abstract
The Science Core B will support activities in all four projects of this IPCAVD Proposal. Core B will be responsible for the production of protein reagents and vaccine immunogens that will be used in Projects One, Two, and Three. Core B will be responsible for the production of recombinant Envelope proteins for analytical studies in Project One, and the production of the Envelope-based immunogens that will be used in for pre-clinical vaccine studies in Project Two. Additionally, Core B will assist in the development of stable protein production cell lines and analytical validation of stably-produced Envelope immunogens in Project Three.
View original record on NIH RePORTER →